Category: Healthcare
-
Date:
Global Bacterial Conjunctivitis Drugs Market Set to Reach USD 4.9 Billion by 2036, Driven by Rising Eye Infection Prevalence and Advancements in Ophthalmic Treatments
The global Bacterial Conjunctivitis Drugs Market has emerged as a significant segment within the ophthalmic pharmaceuticals industry, driven by rising eye infection…
-
Date:
T-Cell Lymphoma Therapeutics Market to Reach USD 5.7 Billion by 2035, Fueled by Advances in Immunotherapy and Targeted Treatments
The global T-Cell Lymphoma Therapeutics Market is poised for substantial growth over the coming decade, driven by the rapid expansion of targeted…
-
Date:
Global Kidney Cancer Drugs Market Set to Reach US$ 13.7 Billion by 2035, Driven by Rising RCC Cases and Advances in Immunotherapy
The global kidney cancer drugs market is witnessing steady expansion, driven by rising disease prevalence, rapid advancements in oncology therapeutics, and increasing…
-
Date:
Uveal Melanoma Treatment Market Expected to Hit USD 2.5 Billion by 2035, Fueled by Growing Disease Awareness
The global Uveal Melanoma Treatment Market is witnessing significant growth due to increasing awareness of rare ocular cancers, advancements in targeted therapies,…
-
Date:
Parenteral Nutrition Market Size Forecast to USD 13.4 Billion by 2035 with Growing Demand for Clinical Nutrition Support – Analysis by Transparency Market Research
Nutrition plays a critical role in patient recovery, disease management, and overall health outcomes. However, for millions of patients suffering from severe…
-
Date:
Controlled Substance Market to Reach USD 169.8 Billion by 2035, Driven by Expanding Therapeutic Demand and Innovations from Johnson & Johnson, Pfizer, and Teva Pharmaceutical Industries
The global controlled substance market was valued at US$ 91.2 billion in 2024 and is projected to reach US$ 169.8 billion by…
-
Date:
Oral Proteins and Peptides Market Worth USD 47.2 Billion by 2035 Amid Rising Demand for Non-Invasive Drug Delivery
The Oral Proteins and Peptides Market is gaining significant momentum as pharmaceutical companies increasingly focus on developing patient-friendly drug delivery systems. Proteins…
-
Date:
Global Synthetic Cannabinoids Market to Surpass USD 19.3 Billion by 2035, Driven by Rising Therapeutic Applications and Neurological Disorder Treatments
The global synthetic cannabinoids market is witnessing substantial growth as pharmaceutical companies, healthcare providers, and research institutions increasingly recognize the therapeutic potential…
-
Date:
Synthetic Cannabinoids Market to Surpass US$ 19.3 Billion by 2035, Driven by Rising Neurological Disorder Treatments and Expanding Cannabinoid-Based Therapeutics
Synthetic Cannabinoids Market Overview Synthetic cannabinoids are laboratory-developed compounds designed to mimic the effects of naturally occurring cannabinoids found in cannabis plants,…
-
Date:
Clinical Trials Market Size Forecast to USD 112.9 Billion by 2035 with Growing Investments in Drug Development – Analysis by Transparency Market Research
Clinical trials are the foundation of modern medicine, serving as the critical pathway through which new drugs, vaccines, medical devices, and treatment…
Olivia
Carter
is a writer covering health, tech, lifestyle, and economic trends. She loves crafting engaging stories that inform and inspire readers.
